Displaying items by tag: school of medicine

Kumar and Locke will be positioned to help guide the national discussion on transplantation policies.

Gregory Friedman, M.D., has received a special grant to test various therapy combinations with a form of the herpes virus to improve anti-tumor immune response in children battling brain cancer.

A comprehensive health-screening program in rural northern KwaZulu-Natal has found a high burden of undiagnosed or poorly controlled non-communicable diseases.

Only 22 early-career researchers were selected as Pew Scholars this year, and Thyme is one of five whose research focus is the brain.

Responsibility for the safety, integrity and scientific validity of the trials fell to 12 experts of the COVID-19 Vaccine Data and Safety Monitoring Board, who now have taken the unusual step of publishing details of their review process.

New findings include a significant increase in risk of death among patients who had recently had chemotherapy.

The first new medication for Alzheimer’s disease in almost 20 years seems to reduce the amount of amyloid peptide in the brain, which may slow the progression of the disease.

In honor of National Cancer Survivors Day, O’Neal Cancer Center patient Charlotte Patterson reflects on her own cancer diagnosis and treatment.